Below is a summary assembled by the Research & Innovation Office (RIO). Please see the Tang Prize website for complete information. The Tang Prize comprises four categories, namely Sustainable ...

Safety and efficacy of two candidates are currently being assessed in investigator-initiated clinical trials. BRC is planning to commence enrollment for Phase 2 and 3 trials by mid 2026. MONTEREY, ...

DURHAM, N.C. & CARLSBAD, Calif.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), and Argonaut Manufacturing ...

LONDON--(BUSINESS WIRE)--Regulatory News: BenevolentAI (“the Company”), a pioneer in integrating artificial intelligence with biopharmaceutical development, today unveils a major strategic overhaul to ...

In process monitoring is important for optimizing cell culture conditions such as nutrient concentrations, cell viability, and metabolite production as well as product quality attributes such as ...

ATCC, the world’s premier biological materials management and standards organization, today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract 75N93023D00009 ...

Solubility is fundamental in successfully developing all classes of therapeutic biopolymers. Contact with stressors related to mechanical stirring or changes in buffer conditions may cause ...

Program further validates Willow's BioOxi™ technology and focus on commercial execution and aligns with its strategic focus on near term revenue generation SUNNYVALE, Calif., Dec. 7, 2023 /PRNewswire/ ...

Leadgene Biosolutions today announces the expansion of its product portfolio following its strategic integration into Leadgene Biomedical. The expanded portfolio supports both early-stage cell line ...

Cook Pharmica, LLC, a privately-held contract development and manufacturing organization serving the biopharmaceutical industry, plans to expand its operations in Bloomington, IN, creating up to 70 ...

The drug development process is driven by both medical need and business opportunity. The process itself is arduous, expensive and time-consuming. Invariably, it takes not only expertise, but robust ...